AU2001244196A1 - Atp binding cassette transporter 1 (abc1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases - Google Patents

Atp binding cassette transporter 1 (abc1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases

Info

Publication number
AU2001244196A1
AU2001244196A1 AU2001244196A AU4419601A AU2001244196A1 AU 2001244196 A1 AU2001244196 A1 AU 2001244196A1 AU 2001244196 A AU2001244196 A AU 2001244196A AU 4419601 A AU4419601 A AU 4419601A AU 2001244196 A1 AU2001244196 A1 AU 2001244196A1
Authority
AU
Australia
Prior art keywords
abc1
diagnosis
treatment
atp binding
binding cassette
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001244196A
Other languages
English (en)
Inventor
Marek Bodzioch
Gerd Schmitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00105820A external-priority patent/EP1136552A1/fr
Priority claimed from EP00106401A external-priority patent/EP1136554A1/fr
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001244196A1 publication Critical patent/AU2001244196A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001244196A 2000-03-20 2001-03-07 Atp binding cassette transporter 1 (abc1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases Abandoned AU2001244196A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00105820 2000-03-20
EP00105820A EP1136552A1 (fr) 2000-03-20 2000-03-20 Polymorphismes du gène codant le transporteur à cassette de fixation à l'ATP 1 (ABC1), et usages pour le diagnostique et le traitement de désordres lipidiques, de maladies cardiovasculaires et de maladies inflammatoires
EP00106401 2000-03-24
EP00106401A EP1136554A1 (fr) 2000-03-24 2000-03-24 Polymorphismes du gène codant le transporteur à cassette de fixation à l'ATP 1 (ABC1), et usages pour le diagnostique et le traitement de désordres lipidiques, de maladies cardiovasculaires et de maladies inflammatoires
PCT/EP2001/002545 WO2001070810A2 (fr) 2000-03-20 2001-03-07 Polymorphismes geniques de transporteur 1 de cassettes de liaison d'atp (abc1) et utilisations de ceux-ci dans le diagnostic et le traitement de troubles lipidiques, de maladies cardio-vasculaires et de maladies inflammatoires

Publications (1)

Publication Number Publication Date
AU2001244196A1 true AU2001244196A1 (en) 2001-10-03

Family

ID=26070688

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001244196A Abandoned AU2001244196A1 (en) 2000-03-20 2001-03-07 Atp binding cassette transporter 1 (abc1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases

Country Status (2)

Country Link
AU (1) AU2001244196A1 (fr)
WO (1) WO2001070810A2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018912A2 (fr) * 1998-09-25 2000-04-06 Bayer Aktiengesellschaft Genes et proteines de cassette de liaison avec atp, destines au diagnostic et au traitement de desordres lipidiques et maladies inflammatoires
FR2796808B1 (fr) * 1999-07-30 2004-03-12 Inst Nat Sante Rech Med Nouvelles applications des transporteurs de type abca
EP1096012A1 (fr) * 1999-10-26 2001-05-02 Aventis Pharma S.A. Acides nucléiques correspondant au gène ABC1 humain et leur application thérapeutique et diagnostique

Also Published As

Publication number Publication date
WO2001070810A3 (fr) 2002-01-03
WO2001070810A2 (fr) 2001-09-27

Similar Documents

Publication Publication Date Title
AU9287401A (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
WO1999049883A3 (fr) Thymosine beta 4 oxydee
AU2002252373A1 (en) Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
MXPA03002814A (es) Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001278852A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
MXPA03005155A (es) 1,2-difenilazetidinonas novedosas, procesos para su preparacion, farmacos que contienen compuestos y su uso para el tratamiento del metabolismo afectado de los lipidos.
EP1123921A4 (fr) Derives de vitamine d 3? et medicaments contre des maladies respiratoires inflammatoires les contenant
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU5980499A (en) Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
AU2002233928A1 (en) Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
AU9551298A (en) Use of coumarin derivatives for the treatment of digestive tract disorders
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU2003252182A1 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
WO1999012933A3 (fr) Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase
WO2003039490A9 (fr) Compositions et procedes diagnostiquant et traitant les troubles mentaux
WO2001042474A3 (fr) Molecules de type interferon et utilisations
AU2001267404A1 (en) Novel compounds for the treatment of inflammatory and cardiovascular diseases
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2001244196A1 (en) Atp binding cassette transporter 1 (abc1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases
IL137598A (en) Oral formulations for treatment of chronic inflammatory disorders of the gastrointestinal tract
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU2002224253A1 (en) Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseases
AU2002324469A1 (en) Substituted-heteroaryl-7-aza(2.2.1)bicycloheptanes for the treatment of disease
AUPQ475499A0 (en) Phosphoglycerate kinase in the treatment of disease